Exthera Medical Corporation
Clinical trials sponsored by Exthera Medical Corporation, explained in plain language.
-
Blood filter device tested to fight COVID-19 organ failure
Disease control OngoingThis trial tests a device called Seraph 100, a blood filter used to treat severe COVID-19. The goal is to see if filtering the blood can reduce organ failure in patients with COVID-19 who are in the intensive care unit. The study enrolled 42 adults with confirmed COVID-19 and org…
Phase: NA • Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Long COVID blood filter study pulled before it began
Disease control TerminatedThis study planned to test a blood filter device called Seraph 100 in 100 people with long COVID. The device was meant to remove harmful substances from the blood during two sessions on consecutive days. However, the study was withdrawn before enrolling any participants, so no re…
Phase: NA • Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New blood filter could save lives in septic shock
Disease control OngoingThis study tests a new blood filtering therapy for adults in the ICU with septic shock, a life-threatening condition caused by severe infection. The treatment aims to remove harmful substances from the blood to help patients recover faster. The trial includes 15 participants and …
Phase: NA • Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC